NASDAQ:KERN - Nasdaq - US00973W3007 - Common Stock - Currency: USD
0.3136
+0.08 (+36.94%)
The current stock price of KERN is 0.3136 USD. In the past month the price decreased by -8.3%. In the past year, price decreased by -61.77%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
SAP | SAP SE-SPONSORED ADR | 59.7 | 330.11B | ||
CRM | SALESFORCE INC | 31.94 | 296.48B | ||
PLTR | PALANTIR TECHNOLOGIES INC-A | 247.2 | 230.78B | ||
ADBE | ADOBE INC | 24.12 | 193.42B | ||
INTU | INTUIT INC | 33.26 | 158.29B | ||
APP | APPLOVIN CORP-CLASS A | 91.48 | 139.37B | ||
MSTR | MICROSTRATEGY INC-CL A | N/A | 77.37B | ||
TEAM | ATLASSIAN CORP-CL A | 87.19 | 74.93B | ||
SNPS | SYNOPSYS INC | 35.46 | 73.40B | ||
CDNS | CADENCE DESIGN SYS INC | 43.27 | 70.85B | ||
WDAY | WORKDAY INC-CLASS A | 36.89 | 68.20B | ||
ROP | ROPER TECHNOLOGIES INC | 31.33 | 61.56B |
Akerna Corp. engages in the provision of software as a service solutions within the cannabis industry that enable regulatory compliance and inventory management. The company is headquartered in Denver, Colorado and currently employs 112 full-time employees. The company went IPO on 2018-02-21. The firm is a provider of enterprise software solutions within the cannabis industry. The firm is engaged in providing an integrated ecosystem of applications and services. The firm's small and medium business products include MJ Platform and Ample Organics provide software-as-a-service (SaaS) offerings for legal cannabis, hemp and cannabidiol businesses. Its data products MJ Analytics (MJA), Akerna Acumen Big Data, E&I, distribution, retail modules, AmpleData. The firm's integrated ecosystem provides integrations with third-party vendors and add-ons that enhance the capabilities of its commercial software platforms. Its regulatory service provides track and trace solutions that allow state governments to monitor compliance of licensed cannabis businesses. Its Leaf Data Systems provides regulatory authorities with visibility into the operations of licensed medical and recreational cannabis businesses.
AKERNA CORP
1550 Larimer Street, Suite 246
Denver COLORADO 80202 US
CEO: Jessica Billingsley
Employees: 112
Company Website: https://ir.akerna.com/
Phone: 18889326537
The current stock price of KERN is 0.3136 USD. The price increased by 36.94% in the last trading session.
The exchange symbol of AKERNA CORP is KERN and it is listed on the Nasdaq exchange.
KERN stock is listed on the Nasdaq exchange.
6 analysts have analysed KERN and the average price target is 0.82 USD. This implies a price increase of 160.2% is expected in the next year compared to the current price of 0.3136. Check the AKERNA CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AKERNA CORP (KERN) has a market capitalization of 3.25M USD. This makes KERN a Nano Cap stock.
AKERNA CORP (KERN) currently has 112 employees.
AKERNA CORP (KERN) has a support level at 0.3 and a resistance level at 0.32. Check the full technical report for a detailed analysis of KERN support and resistance levels.
The Revenue of AKERNA CORP (KERN) is expected to decline by -57.91% in the next year. Check the estimates tab for more information on the KERN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
KERN does not pay a dividend.
AKERNA CORP (KERN) will report earnings on 2024-03-19, after the market close.
AKERNA CORP (KERN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-37.79).
ChartMill assigns a technical rating of 2 / 10 to KERN. When comparing the yearly performance of all stocks, KERN is a bad performer in the overall market: 84.49% of all stocks are doing better.
Over the last trailing twelve months KERN reported a non-GAAP Earnings per Share(EPS) of -37.79. The EPS increased by 83.46% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -821.29% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 43% to KERN. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 95.9% and a revenue growth -57.91% for KERN